| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.46B | 28.26B | 27.56B | 21.17B | 18.61B | 13.98B |
| Gross Profit | 41.72B | 14.08B | 13.84B | 10.47B | 9.65B | 6.63B |
| EBITDA | 30.12B | 10.18B | 10.02B | 7.16B | 7.21B | 4.54B |
| Net Income | 23.18B | 7.57B | 7.84B | 5.62B | 5.88B | 3.55B |
Balance Sheet | ||||||
| Total Assets | 45.10B | 48.59B | 39.96B | 36.30B | 30.23B | 27.27B |
| Cash, Cash Equivalents and Short-Term Investments | 5.13B | 12.74B | 7.01B | 7.38B | 7.59B | 7.35B |
| Total Debt | 2.70B | 4.69B | 4.63B | 4.26B | 4.58B | 4.68B |
| Total Liabilities | 26.10B | 30.11B | 26.51B | 27.49B | 20.09B | 13.40B |
| Stockholders Equity | 18.99B | 18.48B | 13.45B | 8.81B | 10.14B | 13.87B |
Cash Flow | ||||||
| Free Cash Flow | 18.42B | 9.08B | 3.25B | 7.22B | 9.91B | 3.63B |
| Operating Cash Flow | 23.90B | 11.17B | 5.44B | 8.49B | 10.85B | 4.63B |
| Investing Cash Flow | -12.98B | -2.61B | -2.69B | -1.03B | -72.00M | -1.35B |
| Financing Cash Flow | -14.81B | -2.83B | -3.00B | -7.14B | -9.89B | -753.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €365.67B | 39.75 | 53.85% | 0.68% | 22.77% | 37.62% | |
63 Neutral | €27.25B | 35.02 | 21.56% | 0.54% | 19.12% | 42.78% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
53 Neutral | €11.51B | 76.27 | 35.84% | 1.48% | -5.75% | -17.63% |